Neuraxis Stock Technical Analysis
| NRXS Stock | 4.62 0.26 5.96% |
As of the 11th of February 2026, Neuraxis secures the Downside Deviation of 4.78, mean deviation of 3.75, and Risk Adjusted Performance of 0.164. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuraxis, as well as the relationship between them. Please verify Neuraxis jensen alpha and semi variance to decide if Neuraxis is priced some-what accurately, providing market reflects its recent price of 4.62 per share. Given that Neuraxis has jensen alpha of 0.9403, we recommend you to check Neuraxis's last-minute market performance to make sure the company can sustain itself at a future point.
Neuraxis Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neuraxis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeuraxisNeuraxis' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Neuraxis Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 5.0 | Strong Buy | 1 | Odds |
Most Neuraxis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Neuraxis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Neuraxis, talking to its executives and customers, or listening to Neuraxis conference calls.
Is there potential for Biotechnology market expansion? Will Neuraxis introduce new products? Factors like these will boost the valuation of Neuraxis. Anticipated expansion of Neuraxis directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Neuraxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth 0.217 | Return On Assets | Return On Equity |
The market value of Neuraxis is measured differently than its book value, which is the value of Neuraxis that is recorded on the company's balance sheet. Investors also form their own opinion of Neuraxis' value that differs from its market value or its book value, called intrinsic value, which is Neuraxis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Neuraxis' market value can be influenced by many factors that don't directly affect Neuraxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Neuraxis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neuraxis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Neuraxis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Neuraxis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuraxis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuraxis.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Neuraxis on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Neuraxis or generate 0.0% return on investment in Neuraxis over 90 days. Neuraxis is related to or competes with Collplant Biotechnologies, Neurosense Therapeutics, Exicure, Klotho Neurosciences, Enlivex Therapeutics, Cadrenal Therapeutics, and Minerva Neurosciences. Neuraxis is entity of United States. It is traded as Stock on NYSE MKT exchange. More
Neuraxis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuraxis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuraxis upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.78 | |||
| Information Ratio | 0.177 | |||
| Maximum Drawdown | 38.8 | |||
| Value At Risk | (5.86) | |||
| Potential Upside | 7.88 |
Neuraxis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuraxis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuraxis' standard deviation. In reality, there are many statistical measures that can use Neuraxis historical prices to predict the future Neuraxis' volatility.| Risk Adjusted Performance | 0.164 | |||
| Jensen Alpha | 0.9403 | |||
| Total Risk Alpha | 0.4813 | |||
| Sortino Ratio | 0.2002 | |||
| Treynor Ratio | 0.869 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuraxis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuraxis February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.164 | |||
| Market Risk Adjusted Performance | 0.879 | |||
| Mean Deviation | 3.75 | |||
| Semi Deviation | 3.85 | |||
| Downside Deviation | 4.78 | |||
| Coefficient Of Variation | 515.09 | |||
| Standard Deviation | 5.4 | |||
| Variance | 29.2 | |||
| Information Ratio | 0.177 | |||
| Jensen Alpha | 0.9403 | |||
| Total Risk Alpha | 0.4813 | |||
| Sortino Ratio | 0.2002 | |||
| Treynor Ratio | 0.869 | |||
| Maximum Drawdown | 38.8 | |||
| Value At Risk | (5.86) | |||
| Potential Upside | 7.88 | |||
| Downside Variance | 22.81 | |||
| Semi Variance | 14.84 | |||
| Expected Short fall | (4.39) | |||
| Skewness | 1.04 | |||
| Kurtosis | 5.67 |
Neuraxis Backtested Returns
Neuraxis is unstable given 3 months investment horizon. Neuraxis has Sharpe Ratio of 0.24, which conveys that the firm had a 0.24 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.27% are justified by taking the suggested risk. Use Neuraxis Mean Deviation of 3.75, risk adjusted performance of 0.164, and Downside Deviation of 4.78 to evaluate company specific risk that cannot be diversified away. Neuraxis holds a performance score of 18 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.2, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuraxis will likely underperform. Use Neuraxis sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on Neuraxis.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Neuraxis has insignificant reverse predictability. Overlapping area represents the amount of predictability between Neuraxis time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuraxis price movement. The serial correlation of -0.2 indicates that over 20.0% of current Neuraxis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Neuraxis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Neuraxis Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Neuraxis across different markets.
About Neuraxis Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neuraxis on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neuraxis based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neuraxis price pattern first instead of the macroeconomic environment surrounding Neuraxis. By analyzing Neuraxis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neuraxis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neuraxis specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.25 | 0.61 | 0.7 | 1.09 | Days Of Inventory On Hand | 25.53 | 44.7 | 51.4 | 53.02 |
Neuraxis February 11, 2026 Technical Indicators
Most technical analysis of Neuraxis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neuraxis from various momentum indicators to cycle indicators. When you analyze Neuraxis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.164 | |||
| Market Risk Adjusted Performance | 0.879 | |||
| Mean Deviation | 3.75 | |||
| Semi Deviation | 3.85 | |||
| Downside Deviation | 4.78 | |||
| Coefficient Of Variation | 515.09 | |||
| Standard Deviation | 5.4 | |||
| Variance | 29.2 | |||
| Information Ratio | 0.177 | |||
| Jensen Alpha | 0.9403 | |||
| Total Risk Alpha | 0.4813 | |||
| Sortino Ratio | 0.2002 | |||
| Treynor Ratio | 0.869 | |||
| Maximum Drawdown | 38.8 | |||
| Value At Risk | (5.86) | |||
| Potential Upside | 7.88 | |||
| Downside Variance | 22.81 | |||
| Semi Variance | 14.84 | |||
| Expected Short fall | (4.39) | |||
| Skewness | 1.04 | |||
| Kurtosis | 5.67 |
Neuraxis February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Neuraxis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,315 | ||
| Daily Balance Of Power | 0.67 | ||
| Rate Of Daily Change | 1.06 | ||
| Day Median Price | 4.56 | ||
| Day Typical Price | 4.58 | ||
| Price Action Indicator | 0.19 |
Additional Tools for Neuraxis Stock Analysis
When running Neuraxis' price analysis, check to measure Neuraxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuraxis is operating at the current time. Most of Neuraxis' value examination focuses on studying past and present price action to predict the probability of Neuraxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuraxis' price. Additionally, you may evaluate how the addition of Neuraxis to your portfolios can decrease your overall portfolio volatility.